Difference between revisions of "Iron sucrose (Venofer)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA")
Line 24: Line 24:
 
[[Category:Hematology medications]]
 
[[Category:Hematology medications]]
 
[[Category:Iron]]
 
[[Category:Iron]]
[[Category:Drugs FDA approved in 2000]]
+
[[Category:FDA approved in 2000]]

Revision as of 19:38, 30 July 2018

General information

Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.[1][2][3]
Route: IV
Extravasation: no information

  • 1 mL of Venofer provides 20 mg of elemental iron

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

History of changes in FDA indication

  • 11/6/2000: FDA approved "for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD)."

Also known as

  • Brand name: Venofer

References